1. Home
  2. NC vs IPSC Comparison

NC vs IPSC Comparison

Compare NC & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NACCO Industries Inc.

NC

NACCO Industries Inc.

N/A

Current Price

$47.33

Market Cap

379.8M

Sector

Energy

ML Signal

N/A

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.25

Market Cap

441.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NC
IPSC
Founded
1913
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
379.8M
441.9M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
NC
IPSC
Price
$47.33
$2.25
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.25
AVG Volume (30 Days)
11.9K
2.0M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
91.30
EPS
1.17
N/A
Revenue
$104,778,000.00
$109,164,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.60
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$35.43
$0.44
52 Week High
$59.42
$2.97

Technical Indicators

Market Signals
Indicator
NC
IPSC
Relative Strength Index (RSI) 42.58 46.39
Support Level $47.53 $2.14
Resistance Level $51.09 $2.56
Average True Range (ATR) 1.52 0.19
MACD -0.35 -0.01
Stochastic Oscillator 31.80 18.67

Price Performance

Historical Comparison
NC
IPSC

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments: Utility Coal Mining, Contract Mining, and Minerals and Royalties. The Utility Coal Mining segment, operated by North American Coal, manages surface coal mines that are exclusive, long-term fuel providers for power generation companies. The Contract Mining segment, operated by North American Mining, is a provider of a broad range of specialized, long-term contract mining services. The Minerals and Royalties segment, which includes the Catapult Mineral Partners (Catapult) business, acquires and promotes the development of mineral and royalty interests and other related investments.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: